Following the news that Chinese regulators fined foreign manufacturers of infant milk formula $110 million on allegations of price-fixing, the National Development and Reform Commission is reportedly threatening to issue stricter fines in the future. Six companies, including Mead Johnson, were hit with the fines after a four-month probe. China announced the fines on Wednesday. Just one day later, the NDRC said such practices will earn stricter fines: “If we discover firms knowingly breaking the law,” said NDRC head Xu Kunlin, “then fines will be increasingly severe. National media reported the milk formula fines set a record for China; all six companies said they would not contest the fines. The NDRC is currently probing the nation’s pharmaceutical industry, eying 60 companies, both foreign and domestic.
Featured News
California AG Says No Paramount Settlement Talks Scheduled
Aug 25, 2026 by
CPI
Judge Lets Antitrust Case Against 32 US Universities Move Forward
Aug 25, 2026 by
CPI
CoStar Hit With Consolidated Antitrust Challenge Over Property Data
Aug 25, 2026 by
CPI
Express Scripts Wins Dismissal of Nonprofit Pharmacy’s Antitrust Claims
Aug 25, 2026 by
CPI
Draghi, Business Leaders Form Group Focused on European Competitiveness
Aug 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Antipasto
Aug 24, 2026 by
CPI
“Anti-Monopoly” Antitrust Enforcement: Lessons Learned from the Biden Administration
Aug 24, 2026 by
Diana L. Moss
FTC v. Meta: The Importance of Quantitative Evidence in Antitrust
Aug 24, 2026 by
Dennis Carlton, John A. List, Allan Shampine, Hal Sider & Theresa Sullivan
Competitor Information Exchanges: Reducing Market Uncertainty Is What Matters, Not Level Of Detail
Aug 24, 2026 by
Kasia Czapracka, Assimakis Komninos, James Killick & Nina Frie
When Politics Meets Merger Control: 10 Transatlantic Takeaways
Aug 24, 2026 by
Rachel Brandenburger